HVR Cardio Announces New Leadership Team With Hiring Of CTO Tim Girton, CEO Tom Fleming HELSINKI, FINLAND/MINNEAPOLIS, MN, January 11, 2023 – HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve repair, announced today that it has closed on...
Yhtiön saama uusi rahoitus, noin 10,7 miljoonaa euroa, on suurimpia suomalaisia rahoituskierroksia alalla. Sen tavoitteena on siirtyä CathHELIX:in™ tuotekehityksessä kliiniseen vaiheeseen sydämen hiippaläppävuodon hoidossa. Sydämen hiippaläppävuoto on yleisin sydämen läppävika, josta kärsii Euroopassa ja Yhdysvalloissa arviolta 15 miljoonaa ihmistä. Nykyiset kirurgiset hoidot sopivat vain pienelle osalle...
Helsinki, Finland, Oct 26, 2012 – HVR Cardio International Ltd Oy today announced that the investigators at Helsinki University Hospital have successfully completed the recruitment of patients for the first phase of the clinical study evaluating the safety and performance of the HVR Cardio Helix...
Espoo, Finland, 8 February 2021 – HVR Cardio International Ltd Oy (“HVR Cardio”), the cardiovascular device company developing new transformative solutions for mitral valve repair based on its groundbreaking helix technology platform, today announced that it has reached major milestones in its research and development work. HVR...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit...
Espoo, Finland, 6 December 2019 – HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, announces that data on its transcatheter mitral valve will be presented at the ICI Meeting in Tel Aviv, Israel, 8-10 December 2019. Clinical advisor to HVR Cardio,...
Espoo, Finland, 25 September 2019 – HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA), has granted Breakthrough Device designation for its...
HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at Transcatheter Cardiovascular Therapeutics, taking place at the Colorado Convention Center in Denver, Colorado, 29 October – 2 November. Clinical Adviser, Professor Bruno Scheller MD, will...